Gerson Lehrman Group - Intelligently Connecting Institutions and Expertise.

Healthcare

The GLG Healthcare Practice provides access to a global network of more than 55,000 experts from across the entire healthcare industry including physicians, researchers, scientists, and healthcare industry executives.

The Healthcare Practice provides insight into issues affecting the pharmaceutical, biotechnology, medical device, and healthcare services sectors.

Leading Experts on Healthcare

David Ziolkowski, COO/CIO, DOCTOR'S MEDICAL CENTER-SAN PABLODavid Ziolkowski

COO/CIO
DOCTOR'S MEDICAL CENTER-SAN PABLO
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

David Ziolkowski is COO/CIO of Doctors Medical Center in San Pablo, CA. He is responsible for all hospital operations, as well as all Hospital IT functions. Prior to that, Mr. Ziolkowski was Senior Vice President and Chief Information Officer at the Sampson Regional Medical Center in Clinton, NC. He...

Keith Berman, MPH, MBA, Consultant, HEALTH RESEARCH ASSOCIATESKeith Berman, MPH, MBA

Consultant
HEALTH RESEARCH ASSOCIATES
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Keith Berman, MPH, MBA, founded Health Research Associates in 1996. HRA provides reimbursement consulting, business development and market research services to leading biopharmaceuticals, blood products and medical device manufacturers and suppliers. Previously, Mr. Berman worked for ten years in product...

31 recent news post(s)
Hany Salama, Vice President, Commercial Operations, NEOSTRATA COMPANY, INC.Hany Salama

Vice President, Commercial Operations
NEOSTRATA COMPANY, INC.
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Hany Salama, ME, MBA, CPM, is the Vice President, Commercial Operations at The NeoStrata Company. He has global responsibilities for commercial planning, supply chain, and manufacturing operations for all clinical and marketed products. Mr. Salama is also responsible for all new commercial productlaunches...

2 recent news post(s)
Louis Rocco

System Director of Purchasing
HALLMARK HEALTH SYSTEM, INC.
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Louis Rocco is the System Director of Purchasing at Hallmark Health System, in Massachusetts. He has over 25 years of experience in purchasing and has negotiation, analytical, reporting and communication skills in inventory, distribution, purchasing, mailroom, reimbursement and accounts payable background....

1 recent news post(s)
Samir Mehta, MD

Orthopaedic Surgeon
Hospital of the University of Pennsylvania - CC
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Samir Mehta, MD, is an orthopaedic surgeon at the Hospital of the University of Pennsylvania. Previously, he was an Instructor at Harborview Medical Center and Orthopaedic Surgeon and Assistant Professor of Orthopaedic Surgery in the Division of Orthopaedic Trauma at the University of PennsylvaniaHealth...

1 recent event(s)

View All Leading Experts in Healthcare

GLG Study Groups in Healthcare(?)

Study Group Name No. Members
Oncologists (US) 2241
Pharmacists (US) 2077
Obstetricians/Gynecologists 1947
Neurologists 1861
Pediatricians (US) 1695

View All Study Groups in Healthcare

GLG NewsSM Analyses in Healthcare(?)

Analyses are solely the work of the authors and have not been edited or endorsed by GLG.

Will Quest Acquire Vermillion?

November 20, 2009

Ken Powell, President, Genesis Business Development, LLC

Why Quest Will Acquire Vermillion | www.genomeweb.com

Quest Diagnostics has had a known relationship with Vermillion.  Now that Vermillion has received FDA approval for its OVA1 in vitro diagnostic multi-variant index assay (IVDMIA) and Quest has an exclusive three year marketing license and a 17% investment in the company plus additional loans, acquisition...

Peplin merger with Leo pharma

November 19, 2009

Sunil Dhawan, MD, Clinical Assistant Professor of Dermatology, STANFORD UNIVERSITY

Leo Pharma completes merger pact with Peplin | www.pharmabiz.com

The recent merger of Peplin with Leo pharma is of some significance and will benefit both companies. It would have been difficult for Peplin to fully develop and market their flagship product alone.

Watershed Intraocular Lens: The Light Adjsutable Lens (Calhoun Vision)

November 19, 2009

GLG Expert Contributor

Pilot trial for toric correction with light-adjustable lens yields promising early results | ophthalmologytimes.modernmedicine.com

SInce years ophthalmologist await the approval of the LAL Light adjustable lens (calhoun VIsion) as it will represent a watershed in intraocular lens technology. 

Mobile Advertising Set To Soar ? Yes, But What Is The Engine For Growth

November 17, 2009

GLG Expert Contributor

Mobile Advertising Set To Soar | www.mediapost.com

Mobile advertising is set to soar but only if all mobile channels are used and the combination of enabling technology, analytics and advertiser mindset is focused on identifying the exact context of the consumer before ads are served.

Roche Receives H1N1 FDA Emergency Use Authorization

November 16, 2009

Ken Powell, President, Genesis Business Development, LLC

Roche Gets FDA EUA for H1N1 Test Kit | www.genomeweb.com

Roche has received an Emergency Use Authorization from the FDA for its RealTime ready Influenza A/H1N1 Detection Set.  The new H1N1 assay is run on its MagNA Pure LC platform for nucleic acid isolation and its LightCycler 2.0 system for real-time PCR applications.  Roche, the worldwide clinical diagnostics...

View All GLG News in Healthcare

GLG Live Meetings in Healthcare(?)

Upcoming Seminars

December 1, 2009 | New York

Seminar: Hot Topics from Upcoming American Society of Hematology Meeting (New York)

December 2, 2009 | Boston

Seminar: Hot Topics at the Upcoming 51st Annual American Society of Hematology Meeting (Boston)

December 2, 2009 | San Francisco

Seminar: Hot Topics from Upcoming American Society of Hematology Meeting (San Francisco)

View All GLG Live Meetings in Healthcare

GLG Webcasts

Teleconference: Cholesterol War – Merck’s Zetia vs. Abbott’s Niaspan (10:15 AM EST / 15:15 GMT)

November 17, 2009

Teleconference: Will Benlysta be the Miracle Drug for Lupus? (10:00 AM EST / 15:00 GMT)

November 3, 2009

Teleconference: Who Will Win the Anti-Obesity Pill Race? (9:00 AM EST / 13:00 GMT)

October 28, 2009

Teleconference: Future of Gaucher Disease Therapies (11:00 AM EST / 15:00 GMT)

October 27, 2009

Webcast: How Will Oral Cladribine and FTY-720 Impact the Multiple Sclerosis Market?

October 7, 2009

View All GLG Webcasts in Healthcare

Engage a member of GLG Healthcare councils

Get Intelligently Connected
with the world's leading experts

GLG's 850+ Clients Include:

More than 70% of the world's leading
mutual funds
15 of the leading 20
global banks
7 of the leading 10
global private equity firms
5 of the leading 10
AmLaw firms
Fortune 500® Companies
in nearly every industry sector, including pharmaceuticals, insurance, chemicals, energy and computer software

GLG Clients have access to 55,000+ Healthcare Members Globally:

Healthcare Providers
33,000+
Healthcare Industry Experts
17,000+
Cardiologists
2,500+
Hospital Administrators
1,700+
Pharmacists
1,200+

Become a Council Member

GLG Research StudySM

245 U.S.-based neurologists share their opinion of Tysabri for the treatment of multiple sclerosis.

GLG Research Study: 245 Neurologists on Tysabri for MS

GLG Vital SignsSM

Reactions from ten top medical oncologists, powered by the GLG Healthcare CouncilsSM, regarding data presented by Amgen and Bayer at the 34th European Society of Medical Oncology (ESMO) Congress in Berlin the week of September 21, 2009.

GLG Vital Signs: Post-ESMO Impact: Nexavar/Denosumab